Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.19
0.010000.12%
Pre-Market: 5:18 AM EDT
Comments
Loading...
Mind Medicine (NASDAQ:MNMD) Stock, Analyst Ratings, Price Targets, Forecasts
Mind Medicine Inc has a consensus price target of $25.08 based on the ratings of 13 analysts. The high is $55 issued by HC Wainwright & Co. on January 31, 2025. The low is $7 issued by Roth Capital on May 4, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Evercore ISI Group, and Chardan Capital on January 31, 2025, January 28, 2025, and December 20, 2024, respectively. With an average price target of $32.67 between HC Wainwright & Co., Evercore ISI Group, and Chardan Capital, there's an implied 298.86% upside for Mind Medicine Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Evercore ISI Group
Chardan Capital
Oppenheimer
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Mind Medicine
Data brought to you by Benzinga APIs
FAQ
What is the target price for Mind Medicine (MNMD) stock?
The latest price target for Mind Medicine (NASDAQ:MNMD) was reported by HC Wainwright & Co. on January 31, 2025. The analyst firm set a price target for $55.00 expecting MNMD to rise to within 12 months (a possible 571.55% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mind Medicine (MNMD)?
The latest analyst rating for Mind Medicine (NASDAQ:MNMD) was provided by HC Wainwright & Co., and Mind Medicine reiterated their buy rating.
When was the last upgrade for Mind Medicine (MNMD)?
There is no last upgrade for Mind Medicine
When was the last downgrade for Mind Medicine (MNMD)?
There is no last downgrade for Mind Medicine.
When is the next analyst rating going to be posted or updated for Mind Medicine (MNMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mind Medicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mind Medicine was filed on January 31, 2025 so you should expect the next rating to be made available sometime around January 31, 2026.
Is the Analyst Rating Mind Medicine (MNMD) correct?
While ratings are subjective and will change, the latest Mind Medicine (MNMD) rating was a reiterated with a price target of $55.00 to $55.00. The current price Mind Medicine (MNMD) is trading at is $8.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.